Cost figures below reflect 2024 commercial claims data and 2026 Medicare rates as noted inline; actual prices vary by payer, network status, region, and clinical complexity. This is general information, not medical or financial advice.
TL;DR — Quick Verdict
- For the same procedure, commercial insurers paid $1,489 (78%) more at a hospital outpatient department (HOPD) than at an ambulatory surgery center (ASC) in 2024, per Health Affairs.
- Medicare pays an ASC roughly 53% of the HOPD rate for identical work — the entire gap is the facility fee, not the surgeon’s fee.
- Diagnostic colonoscopy runs about 58% more at an HOPD; cataract surgery about 56% more, per Blue Cross Blue Shield Association claims data.
- The savings gap swings hard by payer: one analysis found a $327 differential at Cigna versus $1,673 at UnitedHealthcare.
- Comparison result: the ASC wins on price in nearly every routine, low-complexity case; the HOPD wins when you have serious comorbidities or need hospital-level rescue.
- Recommendation: for elective, low-risk outpatient surgery, price-shop an in-network ASC first and confirm the all-in facility fee before scheduling.
The same knee scope, the same cataract, the same colonoscopy — performed by the same surgeon — can cost you hundreds to thousands of dollars more depending solely on the building you walk into. Health Affairs researchers analyzing 2024 Transparency in Coverage data found commercial insurers paid $1,489 (78%) more at a hospital outpatient department than at an ambulatory surgery center across thirteen common procedures. That difference is almost entirely the facility fee, a line item most patients never see until the bill arrives.
This report breaks down what an ASC and an HOPD actually charge for the same work, why the gap exists, and where each setting genuinely earns its price. You’ll get procedure-level comparisons from Blue Cross Blue Shield Association and American Journal of Managed Care claims studies, a worked out-of-pocket scenario, the three mistakes that cost patients the most, and a clear rule for deciding which site fits your situation. UnitedHealthcare and Cigna data show the gap swings widely by insurer — so the right answer depends on your plan, not just the average.
What Each Setting Charges for the Same Procedure
An ambulatory surgery center is a freestanding facility built for same-day surgery — no overnight beds, no emergency department, lower overhead. A hospital outpatient department is a surgical unit operating under a hospital’s license, which lets it bill a higher facility fee for the identical service. The surgeon’s professional fee is the same in both places; the split happens on the facility side.
Here’s what that looks like in verified claims data, expressed as how much more the HOPD charges for the same procedure.
Sources: Health Affairs (2025); American Journal of Managed Care 2024;30(4):179-184; Blue Cross Blue Shield Association (verify at bcbs.com). Figures are percentage differences, not point prices; absolute dollars vary by market.
Notice the consistency: whether the data comes from Medicare rate-setting, national Blue Cross claims, or 2024 commercial transparency files, the HOPD premium clusters between roughly 44% and 78% for routine outpatient surgery. That’s not a billing quirk — it’s structural. If you’re trying to pin down a specific dollar figure for your own procedure, the using hospital price transparency tools workflow lets you pull facility-specific rates before you book.
Why the Facility Fee Drives the Entire Gap
Follow the money and it always lands on the same line. Medicare pays an ASC approximately 53% of what it pays an HOPD for the identical procedure code, according to CMS payment-system data compiled by billing analysts at MedCare MSO. The surgeon bills the same professional fee at both sites — so every dollar of that gap sits in the facility fee.
Three mechanics create it. First, ASCs start from a lower relative weight in the CMS formula, meaning a smaller base payment before any multiplier. Second, the geographic wage adjustment gives HOPDs roughly 60% weighting versus about 50% for ASCs, further widening the spread. Third, hospitals carry standby capacity — emergency departments, inpatient beds, 24/7 staffing — and fund it partly through outpatient facility fees.
Consider a straightforward screening colonoscopy. At an ASC, the all-in bundled price commonly lands in the $1,250–$2,500 range for a self-pay patient in a mid-size market, per procedure-pricing aggregators; the same case at an HOPD adds the 25–40% facility premium documented in claims studies. The clinical work is identical. What you’re paying extra for is the license on the door, not the scope in the room. Understanding the difference between inpatient vs outpatient status cost differences matters here too, because an HOPD can more easily convert a same-day case into an observation stay that triggers separate charges.
ASC vs HOPD: Which Is Better for Routine Elective Surgery?
Price is not the only variable, so the comparison has to weigh cost against clinical safety margin. On cost, the ASC wins decisively and repeatedly. On safety for healthy, low-risk patients, the evidence shows no meaningful penalty: the AJMC 2024 study found complication rates for colonoscopy, arthroscopy, and cataract surgery were statistically similar across settings — the higher HOPD price bought no measurable quality improvement.
The HOPD earns its premium in a narrower set of cases. If you have significant cardiovascular or pulmonary disease, morbid obesity, a bleeding disorder, or a history of anesthesia complications, the hospital’s ability to escalate to an intensive care unit or convert to an inpatient admission is worth real money in avoided risk. For a fit 55-year-old getting a screening scope, that insurance policy is one you’re paying for and almost certainly won’t use.
Network status compounds the decision. The AJMC analysis found insurers paid $1,042 (110%) more at an in-network HOPD than at an in-network ASC, and patients paid $186 more out of pocket at the in-network HOPD. An out-of-network ASC still often beat an in-network HOPD on total price — though out-of-network exposure carries its own balance-billing risk that the out-of-network billing protections only partly cap.
Verdict
For routine, elective, low-complexity outpatient surgery in a healthy adult, the in-network ASC is the better choice: same surgeon, statistically similar complication rates, and 44–78% lower facility pricing. Reserve the HOPD for cases with serious comorbidities, anticipated complications, or a genuine need for immediate hospital-level backup. Confirm the ASC is in-network and accredited before you commit.
How the Gap Plays Out on Your Actual Bill
Averages hide what you pay, so model it. Take a diagnostic colonoscopy with an ASC all-in price near $1,900 and an HOPD price 58% higher, around $3,000. On a commercial PPO with a $1,886 average deductible (2025 KFF Employer Health Benefits Survey) not yet met and 20% coinsurance after, the arithmetic diverges fast.
At the ASC, you’d pay the full $1,900 toward your deductible. At the HOPD, you’d pay $1,886 to satisfy the deductible plus 20% of the remaining $1,114 — about $223 — for roughly $2,109 out of pocket. Same procedure, a difference of about $209 in your pocket, and more of your annual deductible consumed at the higher-priced site.
Medicare patients see a cleaner version of the same math. In 2026, after the $283 Part B deductible (Federal Register), you owe 20% coinsurance on the Medicare-approved amount. Because the approved amount is lower at an ASC, your 20% is lower too. For cataract surgery, patient-facing estimates put ASC coinsurance near $344 per eye after the deductible versus a higher share at the HOPD’s roughly $2,370 facility benchmark. A Medigap plan absorbs most of that coinsurance — but the underlying facility choice still sets the number your supplement has to cover. If a bill lands higher than these benchmarks, finding and disputing medical billing errors is the first move before you pay.
What Most People Get Wrong About Site-of-Care Costs
Three mistakes cost patients the most, and all three are avoidable before the procedure.
Assuming your surgeon’s office is the only option. Many surgeons operate at both an ASC and an HOPD. Patients often accept whichever the scheduler defaults to — frequently the hospital, which is the higher-priced site. The correct action: ask directly, “Can this be done at a surgery center instead, and what’s the facility fee difference?” The surgeon’s fee doesn’t change, so you lose nothing clinically by asking.
Confusing “in-network” with “lowest cost.” An in-network HOPD can cost more than an out-of-network ASC, per the AJMC data showing 110% higher insurer payments at in-network HOPDs. The consequence is a larger bill despite staying in-network. The correct action: compare the actual negotiated or all-in price at each site, not just network status, using your plan’s cost-estimator tool.
Ignoring the payer-specific spread. The HOPD premium ranged from $327 at Cigna to $1,673 at UnitedHealthcare in the Health Affairs analysis. Assuming a flat “hospitals cost more” rule can misjudge your specific exposure by over $1,000. The correct action: check your own insurer’s rate for your specific CPT code at each facility before scheduling. For elective cases, the price shopping elective procedures approach turns this into a repeatable checklist rather than a guess.
Who Should Choose Each Setting — And Is the ASC Always Worth It?
Start with the clinical filter, then apply the cost filter. The ASC is the right call when you’re an ASA class I or II patient (essentially healthy to mild systemic disease), the procedure is on the ASC-covered list, and an accredited in-network center is available. That covers the large majority of colonoscopies, cataracts, arthroscopies, hand surgeries, and similar same-day work — and it’s where the 44–78% savings live.
The HOPD becomes worth its premium under specific conditions: significant cardiac or pulmonary disease, a history of difficult anesthesia, morbid obesity, anticipated blood loss, or any case where the surgeon flags elevated complication risk. In those situations you’re not overpaying — you’re buying immediate access to inpatient escalation, which an ASC cannot provide.
One caveat keeps the ASC from being an automatic yes: verify accreditation and network status. An unaccredited or out-of-network ASC can erase the savings through balance billing or quality concerns. Accreditation from the Accreditation Association for Ambulatory Health Care or the Joint Commission signals the facility meets the same core safety standards regulators expect. When both boxes are checked and your health is unremarkable, the ASC is worth it in nearly every routine case. When they’re not, the extra scrutiny — or the hospital — is the safer bet. Bringing a written quote also strengthens your position if you later need to hospital bill negotiation strategies on a facility fee that came in above the benchmark.
Frequently Asked Questions
Is a surgery center as safe as a hospital?
For low-risk, healthy patients undergoing routine procedures, yes. The American Journal of Managed Care’s 2024 study of 2019–2020 claims found complication rates for colonoscopy, arthroscopy, and cataract surgery were statistically similar between accredited ASCs and hospital outpatient departments. The higher HOPD price did not buy measurably better outcomes. Patients with serious comorbidities remain safer in a hospital setting with inpatient backup.
How much cheaper is an ASC than a hospital for the same surgery?
It depends on payer and procedure, but the gap is consistently large. Health Affairs found commercial insurers paid $1,489 (78%) more at HOPDs across thirteen procedures in 2024. Blue Cross Blue Shield Association data show diagnostic colonoscopy costs about 58% more and cataract surgery about 56% more at an HOPD. Medicare pays ASCs roughly 53% of the HOPD rate for identical work.
Why does the hospital charge more for the exact same procedure?
The difference is the facility fee, not the surgeon’s fee, which is identical at both sites. Hospitals bill higher facility fees under CMS payment rules that assign them a larger base rate and a higher geographic wage adjustment (about 60% versus roughly 50% for ASCs). Hospitals also fund standby capacity — emergency departments and inpatient beds — partly through outpatient facility charges.
Does Medicare pay differently at an ASC versus a hospital?
Yes. Medicare’s ASC payment rate is approximately 53% of the hospital outpatient rate for the same procedure. After your 2026 Part B deductible of $283 (Federal Register), you pay 20% coinsurance on the Medicare-approved amount — and because that approved amount is lower at an ASC, your coinsurance is lower too. CMS finalized a 2.6% payment increase for both settings in 2026.
How We Researched This Article
This analysis draws on primary and peer-reviewed sources, with every high-risk figure verified against a named institutional source before publication. Commercial price differentials come from the 2025 Health Affairs study analyzing 2024 Transparency in Coverage data provided by Clarify Health for UnitedHealthcare, Cigna, and BlueCross BlueShield across thirteen common procedures, available at Health Affairs. Procedure-level percentage differences for colonoscopy, arthroscopy, and cataract surgery draw on the American Journal of Managed Care’s 2024 observational study (2024;30(4):179-184) using 2019–2020 Blue Cross Blue Shield Axis claims, and the 2025 AJMC site-of-care and network study (2025;31(10):571-574), both at AJMC.
Medicare payment-system figures, including the 2026 OPPS/ASC final rule update and inpatient-only list changes, come from CMS as reported through the CMS 2026 Parts A & B fact sheet and the Federal Register Part B notice. The 2026 Part B deductible ($283) and Part A deductible ($1,736) are taken from these primary CMS sources; a secondary aggregator listing $266 was rejected in favor of the government figure. Out-of-pocket scenarios are modeled, not measured, using 2025 KFF Employer Health Benefits Survey deductible averages and standard 20% coinsurance; they illustrate arithmetic and are not quotes for any specific plan. Procedure-level self-pay ranges reflect 2026 pricing aggregators and are labeled as ranges where provider-specific data was unavailable. Complication-rate comparisons are drawn directly from the AJMC studies; this report does not offer clinical judgment on individual suitability. Research last conducted July 2026. All figures were verified against named primary sources before publication.